Global Home Insulin Delivery (Dosing) Devices Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028

2.2 Home Insulin Delivery (Dosing) Devices Segment by Type

2.2.1 Insulin Pens

2.2.2 Insulin Pumps

2.2.3 Insulin Syringes

2.2.4 Others

2.3 Home Insulin Delivery (Dosing) Devices Sales by Type

2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022)

2.4 Home Insulin Delivery (Dosing) Devices Segment by Application

2.4.1 Hospitals Pharmacy

2.4.2 Online Pharmacy

2.4.3 Retail Pharmacy

2.5 Home Insulin Delivery (Dosing) Devices Sales by Application

2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022)

3 Global Home Insulin Delivery (Dosing) Devices by Company

3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company

3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022)

3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022)

3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022)

3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022)

3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company

3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution

3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region

4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region

4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region

4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth

4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth

4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth

4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth

5 Americas

5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country

5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)

5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)

5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type

5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region

6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022)

6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022)

6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type

6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Home Insulin Delivery (Dosing) Devices by Country

7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)

7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)

7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type

7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country

8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type

8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices

10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices

10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Home Insulin Delivery (Dosing) Devices Distributors

11.3 Home Insulin Delivery (Dosing) Devices Customer

12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region

12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region

12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028)

12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type

12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application

13 Key Players Analysis

13.1 Tandem Diabetes Care

13.1.1 Tandem Diabetes Care Company Information

13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered

13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Tandem Diabetes Care Main Business Overview

13.1.5 Tandem Diabetes Care Latest Developments

13.2 Biocon

13.2.1 Biocon Company Information

13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered

13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biocon Main Business Overview

13.2.5 Biocon Latest Developments

13.3 Roche Holding AG

13.3.1 Roche Holding AG Company Information

13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered

13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Holding AG Main Business Overview

13.3.5 Roche Holding AG Latest Developments

13.4 Insulet Corporation

13.4.1 Insulet Corporation Company Information

13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered

13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Insulet Corporation Main Business Overview

13.4.5 Insulet Corporation Latest Developments

13.5 B. Braun

13.5.1 B. Braun Company Information

13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered

13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 B. Braun Main Business Overview

13.5.5 B. Braun Latest Developments

13.6 BD

13.6.1 BD Company Information

13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered

13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BD Main Business Overview

13.6.5 BD Latest Developments

13.7 Eli Lilly and Company

13.7.1 Eli Lilly and Company Company Information

13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered

13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eli Lilly and Company Main Business Overview

13.7.5 Eli Lilly and Company Latest Developments

13.8 Novo Nordisk

13.8.1 Novo Nordisk Company Information

13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered

13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novo Nordisk Main Business Overview

13.8.5 Novo Nordisk Latest Developments

13.9 Sanofi

13.9.1 Sanofi Company Information

13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered

13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sanofi Main Business Overview

13.9.5 Sanofi Latest Developments

13.10 Wockhardt

13.10.1 Wockhardt Company Information

13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered

13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Wockhardt Main Business Overview

13.10.5 Wockhardt Latest Developments

13.11 Ypsomed Holding

13.11.1 Ypsomed Holding Company Information

13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered

13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ypsomed Holding Main Business Overview

13.11.5 Ypsomed Holding Latest Developments

13.12 Medtronic

13.12.1 Medtronic Company Information

13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered

13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Medtronic Main Business Overview

13.12.5 Medtronic Latest Developments

13.13 Julphar

13.13.1 Julphar Company Information

13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered

13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Julphar Main Business Overview

13.13.5 Julphar Latest Developments

13.14 Beta Bionics

13.14.1 Beta Bionics Company Information

13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered

13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Beta Bionics Main Business Overview

13.14.5 Beta Bionics Latest Developments

13.15 Copernicus

13.15.1 Copernicus Company Information

13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered

13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Copernicus Main Business Overview

13.15.5 Copernicus Latest Developments

13.16 Dance Biopharm

13.16.1 Dance Biopharm Company Information

13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered

13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Dance Biopharm Main Business Overview

13.16.5 Dance Biopharm Latest Developments

13.17 Debiotech

13.17.1 Debiotech Company Information

13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered

13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Debiotech Main Business Overview

13.17.5 Debiotech Latest Developments

13.18 MannKind

13.18.1 MannKind Company Information

13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered

13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 MannKind Main Business Overview

13.18.5 MannKind Latest Developments

13.19 Owen Mumford

13.19.1 Owen Mumford Company Information

13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered

13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Owen Mumford Main Business Overview

13.19.5 Owen Mumford Latest Developments

13.20 SOOIL

13.20.1 SOOIL Company Information

13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered

13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 SOOIL Main Business Overview

13.20.5 SOOIL Latest Developments

13.21 Valeritas

13.21.1 Valeritas Company Information

13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered

13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Valeritas Main Business Overview

13.21.5 Valeritas Latest Developments

13.22 West Pharma

13.22.1 West Pharma Company Information

13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered

13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 West Pharma Main Business Overview

13.22.5 West Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Home Insulin Delivery (Dosing) Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Home Insulin Delivery (Dosing) Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Insulin Pens

Table 4. Major Players of Insulin Pumps

Table 5. Major Players of Insulin Syringes

Table 6. Major Players of Others

Table 7. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)

Table 8. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

Table 9. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & ($ million)

Table 10. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2022)

Table 11. Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)

Table 13. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Table 14. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022)

Table 15. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2022)

Table 16. Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Home Insulin Delivery (Dosing) Devices Sales by Company (2020-2022) & (K Units)

Table 18. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022)

Table 19. Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022)

Table 21. Global Home Insulin Delivery (Dosing) Devices Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution and Sales Area

Table 23. Players Home Insulin Delivery (Dosing) Devices Products Offered

Table 24. Home Insulin Delivery (Dosing) Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Home Insulin Delivery (Dosing) Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Geographic Region (2017-2022)

Table 29. Global Home Insulin Delivery (Dosing) Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Home Insulin Delivery (Dosing) Devices Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Country/Region (2017-2022)

Table 33. Global Home Insulin Delivery (Dosing) Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)

Table 36. Americas Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)

Table 37. Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)

Table 39. Americas Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)

Table 40. Americas Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

Table 41. Americas Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)

Table 42. Americas Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Table 43. APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) & (K Units)

Table 44. APAC Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)

Table 45. APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2017-2022)

Table 47. APAC Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)

Table 48. APAC Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

Table 49. APAC Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)

Table 50. APAC Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Table 51. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)

Table 52. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)

Table 53. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)

Table 55. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)

Table 56. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

Table 57. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)

Table 58. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Home Insulin Delivery (Dosing) Devices

Table 68. Key Market Challenges & Risks of Home Insulin Delivery (Dosing) Devices

Table 69. Key Industry Trends of Home Insulin Delivery (Dosing) Devices

Table 70. Home Insulin Delivery (Dosing) Devices Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Home Insulin Delivery (Dosing) Devices Distributors List

Table 73. Home Insulin Delivery (Dosing) Devices Customer List

Table 74. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Home Insulin Delivery (Dosing) Devices Sales Market Forecast by Region

Table 76. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Home Insulin Delivery (Dosing) Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Home Insulin Delivery (Dosing) Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Home Insulin Delivery (Dosing) Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Home Insulin Delivery (Dosing) Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Application (2023-2028)

Table 94. Tandem Diabetes Care Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 95. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered

Table 96. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Tandem Diabetes Care Main Business

Table 98. Tandem Diabetes Care Latest Developments

Table 99. Biocon Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 100. Biocon Home Insulin Delivery (Dosing) Devices Product Offered

Table 101. Biocon Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Biocon Main Business

Table 103. Biocon Latest Developments

Table 104. Roche Holding AG Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 105. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered

Table 106. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Roche Holding AG Main Business

Table 108. Roche Holding AG Latest Developments

Table 109. Insulet Corporation Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 110. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered

Table 111. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Insulet Corporation Main Business

Table 113. Insulet Corporation Latest Developments

Table 114. B. Braun Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 115. B. Braun Home Insulin Delivery (Dosing) Devices Product Offered

Table 116. B. Braun Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. B. Braun Main Business

Table 118. B. Braun Latest Developments

Table 119. BD Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 120. BD Home Insulin Delivery (Dosing) Devices Product Offered

Table 121. BD Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. BD Main Business

Table 123. BD Latest Developments

Table 124. Eli Lilly and Company Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 125. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered

Table 126. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Eli Lilly and Company Main Business

Table 128. Eli Lilly and Company Latest Developments

Table 129. Novo Nordisk Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 130. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered

Table 131. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Novo Nordisk Main Business

Table 133. Novo Nordisk Latest Developments

Table 134. Sanofi Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 135. Sanofi Home Insulin Delivery (Dosing) Devices Product Offered

Table 136. Sanofi Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Sanofi Main Business

Table 138. Sanofi Latest Developments

Table 139. Wockhardt Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 140. Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered

Table 141. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Wockhardt Main Business

Table 143. Wockhardt Latest Developments

Table 144. Ypsomed Holding Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 145. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered

Table 146. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Ypsomed Holding Main Business

Table 148. Ypsomed Holding Latest Developments

Table 149. Medtronic Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 150. Medtronic Home Insulin Delivery (Dosing) Devices Product Offered

Table 151. Medtronic Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Medtronic Main Business

Table 153. Medtronic Latest Developments

Table 154. Julphar Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 155. Julphar Home Insulin Delivery (Dosing) Devices Product Offered

Table 156. Julphar Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Julphar Main Business

Table 158. Julphar Latest Developments

Table 159. Beta Bionics Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 160. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered

Table 161. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Beta Bionics Main Business

Table 163. Beta Bionics Latest Developments

Table 164. Copernicus Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 165. Copernicus Home Insulin Delivery (Dosing) Devices Product Offered

Table 166. Copernicus Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Copernicus Main Business

Table 168. Copernicus Latest Developments

Table 169. Dance Biopharm Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 170. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered

Table 171. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Dance Biopharm Main Business

Table 173. Dance Biopharm Latest Developments

Table 174. Debiotech Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 175. Debiotech Home Insulin Delivery (Dosing) Devices Product Offered

Table 176. Debiotech Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Debiotech Main Business

Table 178. Debiotech Latest Developments

Table 179. MannKind Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 180. MannKind Home Insulin Delivery (Dosing) Devices Product Offered

Table 181. MannKind Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. MannKind Main Business

Table 183. MannKind Latest Developments

Table 184. Owen Mumford Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 185. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered

Table 186. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 187. Owen Mumford Main Business

Table 188. Owen Mumford Latest Developments

Table 189. SOOIL Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 190. SOOIL Home Insulin Delivery (Dosing) Devices Product Offered

Table 191. SOOIL Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 192. SOOIL Main Business

Table 193. SOOIL Latest Developments

Table 194. Valeritas Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 195. Valeritas Home Insulin Delivery (Dosing) Devices Product Offered

Table 196. Valeritas Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 197. Valeritas Main Business

Table 198. Valeritas Latest Developments

Table 199. West Pharma Basic Information, Home Insulin Delivery (Dosing) Devices Manufacturing Base, Sales Area and Its Competitors

Table 200. West Pharma Home Insulin Delivery (Dosing) Devices Product Offered

Table 201. West Pharma Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 202. West Pharma Main Business

Table 203. West Pharma Latest Developments

List of Figures

Figure 1. Picture of Home Insulin Delivery (Dosing) Devices

Figure 2. Home Insulin Delivery (Dosing) Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Home Insulin Delivery (Dosing) Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Home Insulin Delivery (Dosing) Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Home Insulin Delivery (Dosing) Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Insulin Pens

Figure 10. Product Picture of Insulin Pumps

Figure 11. Product Picture of Insulin Syringes

Figure 12. Product Picture of Others

Figure 13. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type in 2021

Figure 14. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2022)

Figure 15. Home Insulin Delivery (Dosing) Devices Consumed in Hospitals Pharmacy

Figure 16. Global Home Insulin Delivery (Dosing) Devices Market: Hospitals Pharmacy (2017-2022) & (K Units)

Figure 17. Home Insulin Delivery (Dosing) Devices Consumed in Online Pharmacy

Figure 18. Global Home Insulin Delivery (Dosing) Devices Market: Online Pharmacy (2017-2022) & (K Units)

Figure 19. Home Insulin Delivery (Dosing) Devices Consumed in Retail Pharmacy

Figure 20. Global Home Insulin Delivery (Dosing) Devices Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 21. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)

Figure 22. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application in 2021

Figure 23. Home Insulin Delivery (Dosing) Devices Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company in 2021

Figure 25. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Geographic Region in 2021

Figure 27. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)

Figure 28. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country/Region in 2021

Figure 29. Americas Home Insulin Delivery (Dosing) Devices Sales 2017-2022 (K Units)

Figure 30. Americas Home Insulin Delivery (Dosing) Devices Revenue 2017-2022 ($ Millions)

Figure 31. APAC Home Insulin Delivery (Dosing) Devices Sales 2017-2022 (K Units)

Figure 32. APAC Home Insulin Delivery (Dosing) Devices Revenue 2017-2022 ($ Millions)

Figure 33. Europe Home Insulin Delivery (Dosing) Devices Sales 2017-2022 (K Units)

Figure 34. Europe Home Insulin Delivery (Dosing) Devices Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue 2017-2022 ($ Millions)

Figure 37. Americas Home Insulin Delivery (Dosing) Devices Sales Market Share by Country in 2021

Figure 38. Americas Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country in 2021

Figure 39. United States Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Home Insulin Delivery (Dosing) Devices Sales Market Share by Region in 2021

Figure 44. APAC Home Insulin Delivery (Dosing) Devices Revenue Market Share by Regions in 2021

Figure 45. China Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country in 2021

Figure 52. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country in 2021

Figure 53. Germany Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country in 2021

Figure 60. Egypt Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Home Insulin Delivery (Dosing) Devices Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices in 2021

Figure 66. Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices

Figure 67. Industry Chain Structure of Home Insulin Delivery (Dosing) Devices

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles